Cushing's syndrome caused by unsupervised use of ocular glucocorticoids

Endocrine Practice

Volumn 9, Issue 6, 2003, Pages 526-529

  Afandi, Bachar ^a   Toumeh, M Samir ^a   Saadi, Hussein F ^b  

^a TAWAM HOSPITAL   (United Arab Emirates)

^b UNITED ARAB EMIRATES UNIVERSITY   (United Arab Emirates)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENOCORTICOTROPIN ZINC; DIAGNOSTIC AGENT; EYE DROPS; FOLLITROPIN; GLUCOCORTICOID; GLYCOSYLATED HEMOGLOBIN; HYDROCORTISONE; LUTEINIZING HORMONE; PREDNISOLONE; TESTOSTERONE; TETRACOSACTIDE;

ACANTHOSIS NIGRICANS; ADULT; ARTICLE; BLOOD; BONE DENSITY; CASE REPORT; CATARACT; CHEMICALLY INDUCED DISORDER; CUSHING SYNDROME; DEPRESSION; DERMATOMYCOSIS; EYE DISEASE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OSTEOPOROSIS;

ACANTHOSIS NIGRICANS; ADULT; BLOOD GLUCOSE; BONE DENSITY; CATARACT; COSYNTROPIN; CUSHING SYNDROME; DEPRESSION; DERMATOMYCOSES; DIABETES MELLITUS, TYPE 2; EYE DISEASES; FOLLICLE STIMULATING HORMONE; GLUCOCORTICOIDS; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYDROCORTISONE; HYPERTENSION; LUTEINIZING HORMONE; MALE; OPHTHALMIC SOLUTIONS; OSTEOPOROSIS; PREDNISOLONE; TESTOSTERONE;

EID: 1442285912     PISSN: 1530891X     EISSN: None     Source Type: Journal    
DOI: 10.4158/EP.9.6.526     Document Type: Article

References (14)

1. Boscaro M, Barzon L, Fallo F, Sonino N. Cushing's syndrome. Lancet. 2001;357:783-791.
2. Findling JW, Raff H. Diagnosis and differential diagnosis of Cushing's syndrome. Endocrinol Metab Clin North Am. 2001;30:729-747.
3. Cizza G, Nieman LK, Doppman JL, et al. Factitious Cushing syndrome. J Clin Endocrinol Metab. 1996;10: 3573-3577.
4. O'Shaughnessy IM, Raff H, Findling JW. Factitious Cushing's syndrome: discovery with use of a sensitive immunoradiometric assay for corticotropin. Endocr Pract. 1995;1:327-329.
5. Raff H. Suppression of the hypothalamic-pituitary-adrenal axis and other systemic effects of inhaled corticosteroids in asthma. Endocrinologist. 1998;8:9-14.
6. Steelman J, Kappy M. Adrenal suppression and growth retardation from ocular corticosteroids. J Pediatr Ophthalmol Strabismus. 2001;38:177-178.
7. Findlay CA, Macdonald JF, Wallace AM, Geddes N, Donaldson MD. Childhood Cushing's syndrome induced by betamethasone nose drops, and repeat prescriptions. BMJ. 1998;317:739-740.
8. Burger AL, Stanton SF,Wilson JD. Cushing's syndrome due to surreptitious inhalation of fluticasone propionate. Aust N Z J Med. 1999;29:94-95.
9. Cook LJ, Frienkel RK, Zugerman C, Levin DL, Radtke R. Iatrogenic hyperadrenocorticism during topical steroid therapy: assessment of systemic effects by metabolic criteria. J Am Acad Dermatol. 1982;6:1054-1060.
10. Rubin B, Palestine AG. Complications of corticosteroid and immunosuppressive drugs. Int Ophthalmol Clin. 1989; 29:159-171.
11. Salminen L. Review: systemic absorption of topically applied ocular drugs in humans. J Ocul Pharmacol. 1990; 6:243-249.
12. Burch PG, Migeon CJ. Systemic absorption of topical steroids. Arch Ophthalmol. 1968;79:174-176.
13. Ozerdem U, Levi L, Cheng L, Song MK, Scher C, Freeman WR. Systemic toxicity of topical and periocular corticosteroid therapy in an 11-year-old male with posterior uveitis. Am J Ophthalmol. 2000;130:240-241.
14. Romano PE, Traisman HS, Green OC. Fluorinated corticosteroid toxicity in infants. Am J Ophthalmol. 1977;84: 247-250.